genedrive (LON:GDR) Shares Down 15.1% – Should You Sell?

genedrive plc (LON:GDR)’s stock price fell 15.1% during trading on Thursday . The company traded as low as GBX 1.55 ($0.02) and last traded at GBX 1.55 ($0.02). 5,960,786 shares changed hands during trading, an increase of 109% from the average session volume of 2,857,632 shares. The stock had previously closed at GBX 1.83 ($0.02).

genedrive Stock Up 0.3 %

The company has a market cap of £8.69 million, a P/E ratio of -0.43 and a beta of -0.04. The company’s 50-day moving average is GBX 2.03 and its two-hundred day moving average is GBX 2.16. The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52.

genedrive (LON:GDR) last posted its earnings results on Thursday, March 27th. The company reported GBX (0.40) (($0.01)) EPS for the quarter. genedrive had a negative return on equity of 191.22% and a negative net margin of 1,412.18%. As a group, equities analysts predict that genedrive plc will post 209.9999867 earnings per share for the current fiscal year.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.